![David Stamler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Stamler
Directeur Général chez
ALTERITY THERAPEUTICS LIMITED
Fortune : 758 821 $ au 30/06/2026
Profil
David A. Stamler is Chief Executive Officer, MD & Director at Alterity Therapeutics Ltd. since 2025.
Former roles include Vice President-Clinical Development & Therapeutic at Teva Pharmaceutical Industries Ltd. from 2015 to 2017, Chief Medical Officer at Auspex Pharmaceuticals, Inc. from 2011 to 2015, Chief Medical Officer & Senior Vice President at XenoPort, Inc. from 2008 to 2010, Chief Scientific Officer & Head-Drug Development at Prestwick Pharmaceuticals, Inc. from 2005 to 2008, Senior Global Project Leader-CNS Diseases at Fujisawa Pharmaceutical Co., Ltd. from 2003 to 2005, Vice President-Research & Development at Fujisawa Healthcare, Inc. from 2003 to 2005, Vice President- Clinical Research Center at Astellas Research Institute of America LLC from 2000 to 2003, Director-Clinical Research at Abbott Laboratories from 1993 to 1997.
Education includes undergraduate studies at The University of Chicago and a doctorate from Pritzker School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 1 904 862 ( 0,88 % ) | 758 821 $ | 30/06/2026 |
Postes actifs de David Stamler
| Sociétés | Poste | Début |
|---|---|---|
| ALTERITY THERAPEUTICS LIMITED | Directeur Général | 07/01/2021 |
Anciens postes connus de David Stamler
| Sociétés | Poste | Fin |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/01/2017 |
| AUSPEX PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 05/05/2015 |
| XENOPORT, INC. | Directeur Technique/Scientifique/R&D | 19/11/2010 |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Directeur Technique/Scientifique/R&D | 01/01/2008 |
Fujisawa Pharmaceutical Co., Ltd.
 Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals and medical products | Corporate Officer/Principal | 01/01/2005 |
Formation de David Stamler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals and medical products | Health Technology |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
Alterity Therapeutics Ltd.
 Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fujisawa Healthcare, Inc. | |
Astellas Research Institute of America LLC
 Astellas Research Institute of America LLC Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical research & development company | Commercial Services |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
